Search results
FDA panel OKs new COVID vaccine for fall
Medical Xpress· 12 hours agoDr. Peter Marks, who oversees the FDA's vaccine division, urged the committee to consider encouraging the mRNA vaccine makers to focus on the latest...
FDA advisers: Target JN.1 strain in fall’s COVID vaccine
The Columbian· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KTBS Shreveport· 1 day agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S., does the committee recommend a monovalent JN.1-lineage ...
COVID vaccine makers ready updated shots for fall immunization drive (NYSE:PFE)
Seeking Alpha· 2 days agoPfizer (PFE), BioNTech (BNTX), Moderna (MRNA) and Novavax (NVAX) reaffirm commitment to provide...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
AOL· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall — targeting a version of ...
FDA advisors unanimously agree on COVID JN.1-lineage vaccine for fall (NYSE:PFE)
Seeking Alpha· 1 day agoA panel of advisors unanimously agrees on the need for a monovalent COVID-19 shot targeting the JN.1...
COVID shots for JN.1 variant neutralize newer strains, vaccine makers say
WSAU Wausau· 2 days ago(Reuters) - COVID-19 vaccine makers said data from animals studies showed their 2024-25 shots...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
Stamford Advocate· 1 day agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 1 day agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 2 days agoA few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy...
